Cell adhesion molecules: Expression and function in acute myeloid leukemia;Molecules d'adhesion cellulaire: Expression et fonction dans les leucemies aigues myeloides

Bulletin du Cancer

Volumn 86, Issue 3, 1999, Pages 265-277

  Thomas, Xavier ^a   Anglaret, Bruno ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CENTRE HOSPITALIER DE VALENCE   (France)

Author keywords

Acute myeloid leukemia; Bone marrow microenvironment; Cell adhesion

Indexed keywords

CELL ADHESION MOLECULE; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL TRANSPORT; CELLULAR DISTRIBUTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; LEUKEMOGENESIS; PROTEIN EXPRESSION; REVIEW; ACUTE DISEASE; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; METABOLISM; MYELOID LEUKEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE DISEASE; CELL ADHESION; CELL ADHESION MOLECULES; EXTRACELLULAR MATRIX; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; NEOPLASM PROTEINS;

EID: 0033085277     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (179)

1. Greer JP, Kinney MC. Acute nonlymphocytic leukemia. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (Eds). Wintrobe's clinical hematology. Lea & Figiber, Philadelphia, 1993:1920-45.
2. McCauley DL. Treatment of adult acute leukemia. Clin Pharm 1992; 11: 767-96.
3. Miller KB. Clinical manifestations of acute myeloid leukemia. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Siberstein LE, eds. Hematology, basic principles and practice. New York, Churchill Livingstone, 1995: 993-1004.
4. Lichtman MA. The ultrastructure of the hematopoietic environment of the marrow: a review. Exp Hematol 1981; 9: 391-401.
5. + hematopoietic cells in normal human bone marrow and leukemia. Ann Hematol 1992; 65: 169-74.
6. Dexter TM, Coutinho LH, Spooncer E, Heyworth CM, Daniel CP, Schiro R, et al. Stromal cells in haematopoesis. In: Molecular control of haematopoiesis. Chichester, Wiley, 1990: 76-95.
7. Whitlock CA, Witte ON. Long-term cultures of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 1982; 79: 3608-11.
8. Kincade PW. Cell interaction molecules and cytokines which participate in B lymphopoiesis. Baillière's Clin Haematol 1992; 5: 575-98.
9. Campbell AD, Long MW, Wicha MS. Haemonectin, a bone marrow adhesion protein specific for cells of granulocyte lineage. Nature 1987; 329: 744-6.
10. Klein G, Beck S, Müller CA. Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment. J Cell Biol 1993; 123: 1027-35.
11. Klein G, Müller CA, Tillet E, Chu ML, Timpl R. Collagen type VI in the human bone marrow microenvironment: a strong cytoadhesive component. Blood 1995; 86: 1740-8.
12. Lerat H, Lissitsky JC, Singer JW, Keating A, Herve P, Charbord P. Role of stromal cells and macrophages in fibronectin biosynthesis and matrix assembly in human long-term marrow cultures. Blood 1993; 82: 1480-92.
13. Long MW, Dixit VM. Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells. Blood 1990; 75: 2311-8.
14. Zuckerman KS, Wicha MS. Extracellular matrix production by the adherent cells of long-term murine bone marrow cultures. Blood 1983; 61: 540-7.
15. Gallagher JT, Spooncer E, Dexter TM. Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J Cell Sci 1983; 63: 155-71.
16. Ruoslahti E. Fibronectin and its receptors. Ann Rev Biochem 1988; 57: 375-413.
17. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989; 109: 863-75.
18. Wu C, Bauer JS, Juliano RL, McDonald JA. The α5β1 integrin fibronectin receptor, but not the α5 cytoplasmic domain, functions in an early and essential step in fibronectin matrix assembly. J Biol Chem 1993; 268: 21883-8.
19. Verfaillie CM, McCarthy JB, McGlave PB. Differentiation of primitive human multipotent hematopoietic progenitors is accompanied by alteration in their interactions with fibronectin. J Exp Med 1991; 174: 693-703.
20. Bornstein P. Thrombospondins: structure and regulation of expression. FASEB J 1992; 6: 3290-9.
21. Long WM, Briddell R, Walter AW, Bruno E, Hoffman R. Human hematopoietic stem cell adherence to cytokines and matrix molecules. J Clin Invest 1992; 90: 251-5.
22. Koenigsmann M, Griffin JD, DiCarlo J, Cannistra SA. Myeloid and erythroid progenitor cells from normal bone marrow adhere to collagen type I. Blood 1992; 79: 657-65.
23. Liesveld JL, Winslow JM, Kempski MC, Ryan DH, Brennan JK, Abboud CN. Adhesive interactions of normal and leukemic human CD34′ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components. Exp Hematol 1991; 19: 63-70.
24. Liesveld JL, Winslow JM, Frediaini KE, Ryan DH, Abboud CN. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 1993; 81: 112-21.
25. Siczkowski M, Clarke D, Gordon MY. Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate. Blood 1992; 80: 912-9.
26. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990; 171: 477-88.
27. Caldwell J, Palsson BO, Locey B, Emerson SG. Culture perfusion schedules influence the metabolic activity and growth factor production rates of human bone marrow stromal cells. J Cell Physiol 1991; 147: 344-53.
28. Kittler ELW, McGrath H, Temeles D, Crittenden RB, Kister VH, Quesenberry PJ. Biological significance of constitutive and subliminal growth factor production by bone marrow stroma. Blood 1992; 79:3168-78.
29. Quesenberry PJ. Stroma-dependent hematolymphopoietic stem cells. Curr Top Microbiol Immunol 1992; 177: 151-66.
30. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987; 326: 403-5.
31. Rapraeger AC, Krufka A, Olwin BB. Requirement of heparin-sulphate for b-FGF mediated fibroblast growth and myoblast differentiation. Science 1991; 252: 1705-8.
32. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988; 332: 376-8.
33. Toksoz D, Zsebo KM, Smith HA, Hu S, Brankow D, Suggs SV, et al. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 1992; 89: 7350-4.
34. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGFβ. Blood 1990; 75: 96-101.
35. Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, et al. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 1990; 344: 442-4.
36. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 1991; 78: 110-7.
37. Gordon MY, Hibbin JA, Dowding C, Gordon-Smith EC, Goldman JM. Separation of human blast progenitors from granulocytic, erythroid, megakaryocytic, and mixed colony-forming cells by «panning» on cultured marrow-derived stromal layers. Exp Hematol 1985; 13: 937-40.
38. Liesveld JL, Abboud CN, Duerst RE, Ryan DH, Brennan JK, Lichtman MA. Characterization of human marrow stromal cells: role in progenitor cell binding and granulopoiesis. Blood 1989; 73: 1794-800.
39. Verfaillie CM, Blackolmer K, McGlave P. Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 1990; 172: 509-20.
40. Hemler ME. VLA proteins in the integrin family: structure, function and their role on leukocytes. Ann Rev Immunol 1990; 8: 365-400.
41. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
42. Rosales C, O'Brien V, Kornberg L, Juliano R. Signal transduction by cell adhesion receptors. Biochem Biophys Acta 1995; 1242: 77-98.
43. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14.
44. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4: 2868-80.
45. + cells to fibronectin in an activation-dependent way. Blood 1993; 81: 344-51.
46. Simmons PJ, Masinovsky B, Longenecker BM, Berenson R, Torok-Storb B, Gallatin W. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992; 80: 388-95.
47. hi stem cells to bone marrow stroma. J Clin Invest 1992; 90: 358-67.
48. Williams DA, Rios M, Stephens C, Patel VP. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 1991; 352: 438-41.
49. Papayannopoulou T, Nakamato B. Systemic treatment of primates with anti-VLA4 leads to an immediate egress of hemopoietic progenitors to periphery. Blood 1992; 78: 255a.
50. Papayannopoulou T, Brice M. Integrin expression profiles during erythroid differentiation. Blood 1992; 79: 1686-94.
51. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992; 258: 964-9.
52. McEver RP. Leukocyte-endothelial cell interactions. Curr Opin Cell Biol 1992; 4: 840-9.
53. Spertini O, Kansas GS, Munro JM, Griffin JD, Tedder TF. Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin. Nature 1991; 349: 691-4.
54. Johnston GI, Cook RG, McEver RP. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989; 56: 1033-44.
55. Levinovitz A, Mulhoff J, Isenmann S, Vestweber D. Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells. J Cell Biol 1993; 121: 449-59.
56. Hardy CL, Matsuoka T, Tavassoli M. Distribution of homing protein on hemopoietic stromal and progenitor cells. Exp Hematol 1991;19:968-72
57. Matsuoka T, Hardy C, Tavassoli M. Characterization of membrane homing receptors in two cloned murine hemopoietic progenitor cell lines. J Clin Invest 1989; 83: 904-11.
58. Cybulsky MI, Fries JWU, Williams AJ, Sultan P, Davis VM, Gimbrone MA Jr, et al. Alternative splicing of human VCAM-1 in activated vascular endothelium. Am J Pathol 1991; 138: 815-24.
59. Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher ED. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 1988; 141: 1615-23.
60. Dittel BN, McCarthy JB, Wayner EA, LeBien TW. Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 1993; 81: 2272-82.
61. Ryan DH, Nuccie BL, Abboud CN, Winslow JM. Vascular adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J Clin Invest 1991; 88: 995-1004.
62. Marlin SD, Springer TA. Purified intracellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987; 51: 813-21.
63. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339: 61-3.
64. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC. L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993; 366: 695-8.
65. Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993; 74: 185.
66. Muller WA, Weigl SA, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449-60.
67. Simmons DL, Walker C, Power C, Pigott R. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med 1990; 171: 2147-52.
68. Fawcett J, Buckley C, Holness CL, Bird IN, Spragg JH, Saunders J, Harris A, Simmons DL. Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J Cell Biol 1995; 128: 1229-41.
69. Murray BA, Owens GC, Prediger EA, Crossin KL, Cunnhingham BA, Edelman GM. Cell surface modulation of the neural cell adhesion molecule resulting from alternative mRNA splicing in a tissue-specific developmental sequence. J Cell Biol 1986; 103: 1431-9.
70. Thomas PS, Pietrangeli CE, Hayashi SI, Schachner M, Goridis C, Low M, Kincade PW. Demonstration of neural cell adhesion molecules on stromal cells that support lymphopoiesis. Leukemia 1988; 2: 171-5.
71. Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989; 169: 2233-8.
72. + malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia 1993; 7: 853-8.
73. Fern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992; 79: 2432-7.
74. Miller JS, McCarthy JB, McGrave PB. Neural cell adhesion molecule (NCAM) is expressed on the surface of human myeloid cells from chronic myelogenous leukemia (CML) patients. Blood 1991; 78: 108a.
75. Van Camp B, Durie BGM, Spier C, De Waela M, Van Riet I, Vela E, et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 1990; 76: 377-82.
76. Van Riet I, Van Camp B. The involvement of adhesion molecules in the biology of multiple myeloma. Leuk Lymphoma 1993; 9: 441-52.
77. Gordon MY, Riley GP, Clarke D. Heparan sulphate is necessary for adhesive interactions between human early hemopoietic progenitor cells and the extracellular matrix of the marrow microenvironment. Leukemia 1988; 2: 804-9.
78. Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 1992; 116: 81725.
79. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992; 267: 4732-9.
80. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-101.
81. Healy L, May G, Gale K, Grosveld F, Greaves M, Enver T. The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci USA 1995; 92: 12240-4.
82. + cells. Blood 1992; 80: 429-36.
83. Kansas GS, Muirhead MJ, Dailey MO. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 1990; 76: 2483-92.
84. Dorschkind MK. Regulation of hemopoiesis by bone marrow stromal cells and their products. Ann Rev Immunol 1990; 8: 111.
85. Patel VP, Lodish H. A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes. J Cell Biol 1987; 105: 3105-18.
86. Ryan DH, Tang J. Regulation of human B cell lymphopoiesis by adhesion molecules and cytokines. Leuk Lymphoma 1995; 17: 375-89.
87. Nolta J, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 1995; 86: 101-10.
88. Young JC, Varma A, DiGustio D, Backer MP. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 1996; 87: 545-56.
89. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fässler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1-integrins. Nature 1996; 380: 171-5.
90. Papayannopoulou T, Nakamoto B. Peripheralization of hematopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA 1993; 90: 9374-8.
91. Moritz T, Patel VP, Williams DA. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 1994; 93: 1451-8.
92. Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 1996; 271: 499-502.
93. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 1993; 262: 1572-5.
94. Symington BE. Fibronectin receptor modulates cyclin-dependent kinase activity. J Biol Chem 1992; 267: 25744-7.
95. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233-9.
96. Dasrych J, Metcalf D. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 1994; 152: 213-9.
97. Kinashi T, Springer TA. Steel factor and c-kit regulate cell-matrix adhesion. Blood 1994; 83: 1033-8.
98. Kovach NL, Lin N, Yednock T, Harlan JM, Broudy VC. Stem cell factor modulates avidity of α4β1 and α5β1 integrins expressed on hematopoietic cell lines. Blood 1995; 85: 159-67.
99. Levesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 1995; 181: 1805-15.
100. Kortlepel K, Bendall LJ, Gottlieb DJ. Human acute myeloid leukemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia 1993; 7: 1174-9.
101. Bellon T, Lopez-Rodriguez C, Rubio MA, Jochems G, Bernabeu C, Corbi AL. Regulated expression of p150.95 (CD11c/CD18; αX/β2) and VLA-4 (CD49d/CD29; α4/β1) integrins during myeloid cell differentiation. Eur J Immunol 1994; 24: 41-7.
102. Denkers IAM, De Jong-De Boer TJ, Beelen RHJ, Ossenkoppele GJ, Nauta JJP, Langenhuijsen MMAC. Adhesive capacity of human longterm bone marrow cultures from normals and patients with acute myeloid leukaemia: the influence of adhesion molecules. Leuk Res 1993; 17: 255-61.
103. + cells to endothelial monolayers. Leukemia 1994; 8: 2111-7.
104. Reuss-Borst MA, Klein G, Waller HD, Müller CA. Differential expression of adhesion molecules in acute leukemia. Leukemia 1995; 9: 869-74.
105. + hematopoietic cells. Exp Hematol 1992; 20: 24-33.
106. Vila L, Thomas X, Campos L, Sabido O, Archimbaud E. Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics. Exp Hematol 1995; 23: 514-8.
107. Denkers IAM, De Jong-De Boer TJ, Beeline RHJ, Ossenkoppele GJ, Langenhuijsen MMAC. VLA molecule expression may be involved in the release of acute myeloid leukemic cells from the bone marrow. Leuk Res 1992; 16: 469-74.
108. Archimbaud E, Thomas X, Vila L, Sabido O, Campos L. Expression of adhesion molecules in adult acute leukemia. In: Abraham NG, Levine AS and Takaku F, eds. Molecular biology of haematopoiesis III. Intercept, Andover, 1994; 3: 305-12.
109. Thomas X, Anglaret B, Bailly M, Maritaz O, Magaud JP, Archimbaud E. Differential adhesiveness between blood and marrow leukemic cells having similar pattern of VLA adhesion molecule expression. Leuk Res 1998; 22: 953-60.
110. Lukashev ME, Sheppard D, Pytela R. Disruption of integrin function and induction of tyrosine phosphorylation by the autonomously expressed β1 integrin cytoplasmic domain. J Biol Chem 1994; 269: 18311-4.
111. Yoder MC, Williams DA. Matrix molecule interactions with hematopoietic stem cells. Exp Hematol 1995; 23: 961-7.
112. Soligo D, Schiro R, Luksch R, Manara G, Quirici N, Parravicini C, Deliliers G. Expression of integrins in human bone marrow. Br J Haematol 1990; 76: 323-32.
113. Verfaillie C, Benis A, Iida J, McGlave P, McCarthy J. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin α4β1 and the CD44 adhesion receptor. Blood 1994; 84: 1802-11.
114. Coulombel L, Vuillet M, Leroy C, Tchernia G. Lineage and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts. Blood 1988; 71: 329-34.
115. Tsai S, Patel V, Beaumont E, Lodish H, Nathan D, Sieff C. Differential binding of erythroid et myeloid progenitors to fibroblasts and fibronectin. Blood 1987; 69: 1587-94.
116. Weinstein R, Riordan M, Wenc K, Kreczko S, Zhou M, Dainiak N. Dual role of fibronectin in hematopoietic differentiation. Blood 1989; 73: 111-6.
117. Vuillet-Gaugler M, Breton-Gorius J, Vainchenker W, Guichard J, Leroy C, Tchernia G, et al. Loss of attachment to fibronectin with terminal erythroid differentiation. Blood 1990; 75: 865-73.
118. Patel V, Lodish H. The fibronectin receptor on mammalian erythroid precursor cells: characterization and developmental regulation. J Cell Biol 1986; 102: 449-56.
119. Giancotti FG, Ruoslahti E. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of chinese hamster ovary cells. Cell 1990; 60: 849-59.
120. FAK and reduces proliferation in vitro and in vivo. Exp Hematol 1995; 23: 937.
121. Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Leukemia 1994; 8: 1900-5.
122. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993; 74: 423-31.
123. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuoro T, Azuma I. Role of aminopeptidase N (CD13) in tumor cell invasion and extracellular matrix degeneration. Int J Cancer 1993; 54: 137-43.
124. Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PML/RARα isoform, and CD13 expression in patients treated with alltrans retinoic acid. Blood 1994; 84: 3843-9.
125. Spertini O, Callegari P, Cordey AS, Hauert J, Joggi J, von Fliedner V, et al. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium. Blood 1994; 84: 1249-56.
126. Südhoff T, Wehmeier A, Kliche KO, Aul C, Schlömer P, Bauser U, et al. Levels of circulating endothelial adhesion molecules (sE-selectin and sVCAM-1) in adult patients with acute leukemia. Leukemia 1996; 10: 682-6.
127. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule-1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989;243: 1160-5.
128. Foxall C, Watson SR, Dowbenko D, Fennie C, Lasky LA, Kiso M, et al. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis-x oligosaccharide. J Cell Biol 1992; 117: 895-902.
129. Zannettino ACW, Berndt MC, Butcher C, Butcher EC, Vadas MA, Simmons PJ. Primitive human hematopoietic progenitors adhere to Pselectin (CD62P). Blood 1995; 86: 3466-77.
130. Archimbaud E, Thomas X, Campos L, Fiere D, Dore JF. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance. Leuk Res 1992; 16: 673-80.
131. Archimbaud E, Thomas X, Campos L, Magaud JP, Dore JF, Fiere D. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship within initial characteristics and prognosis. Leukemia 1992; 6: 265-71.
132. Ross L, Davis CM, Molony L. A truncated recombinant intercellular adhesion molecule-1 inhibits adhesion of leukemic cell lines to upregulated endothelial cells. In vitro Cell Dev Biol 1994; 30A: 875-80.
133. Tallman MS, Hakimian D, Shaw JM, Lissner GS, Russell EJ, Variakojis D. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol 1993; 11: 690-7.
134. Reuss-Borst MA, Ning Y, Klein G, Müller CA. The vascular cell adhesion molecule (VCAM-1) is expressed on a subset of lymphoid and myeloid leukemia. Br J Haematol 1995; 89: 299-305.
135. + myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 1994; 84: 244-55.
136. Païetta E, Gallagher RE, Wiernik PH. Myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as FAB-M3 acute myeloid leukemia. Blood 1994; 84: 2824-5.
137. Thomas X, Anglaret B, Campos L, Thiebaut A, Sabido O, Bailly M, et al. Expression of β1-integrins and pseudo-immunoglobulins on acute promyelocytic leukemia cells and its modifications during in vitro differentiation. Leuk Res 1998; 22: 61-8.
138. Ghaffari S, Dougherty GJ, Lansdorp PM, Eaves AC, Eaves CJ. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 1995; 86: 2976-85.
139. Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 1990; 75: 589-95.
140. Bradstock KF, Gottlieb DJ. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk Lymphoma 1995; 18: 1-16.
141. Thomas X, Anglaret B, Adeleine P, Maritaz O, Bailly M, Fiere D, et al. Influence of malignant cell clonogenic capacities and position along the maturation pathway on their susceptibility to lymphokine-activated killer cell cytotoxicity. Leuk Lymphoma 1998; 28: 343-53.
142. Palucka AK, Porwit A, Reizenstein P. Resistance of leukemic blast to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties. Eur J Haematol 1991; 47: 123-7.
143. Thomas X, Vila L, Campos L, Sabido O, Archimbaud E. Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome. Leuk Lymphoma 1995; 19: 295-300.
144. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia 1994; 8: 823-6.
145. Vidriales MB, Orfao A, Gonzales M, Hernandez JM, Lopez-Berges MC, Garcia MA, et al. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia. Leukemia 1993; 7: 2026-9.
146. Banu N, Wang JF, Deng B, Groopman JE, Avraham H. Modulation of megakaryopoiesis by thrombopoietin: the c-mpl ligand. Blood 1995; 86: 1331-8.
147. Cavenaugh JD, Gordon-Smith EC, Gibson FM, Gordon MY. Acute myeloid leukaemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular cell adhesion molecule-1 (VCAM-1). Br J Haematol 1993; 85: 285-91.
148. Clark BR, Gallagher JT, Dexter TM. Cell adhesion in the stromal regulation of haematopoiesis. Baillières Clin Haematol 1992; 5: 619-52.
149. Tavassoli M, Minguell JJ. Homing of hemopoietic progenitor cells to the marrow. Proc Soc Exp Biol Med 1991; 196: 367-73.
150. Bendall LJ, Kortlepel K, Gottlieb DJ. Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms. Blood 1993; 82: 3125-32.
151. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-6.
152. + progenitor cells: potential regulatory checkpoints for cellular traffic. Leuk Lymphoma 1994; 14: 19-28.
153. Simmons PJ, Zanettion A, Gronthos S, Leavesley D. Potential adhesion mechanisms for localization of haemopoietic progenitors to bone marrow stroma. Leuk Lymphoma 1994; 12: 353-63.
154. Simmons PJ, Leavesley DI, Levesque JP, Swart BW, Haylock DN, To LB, et al. The mobilization of primitive hemopoietic progenitors into the peripheral blood. Stem Cells 1994; 12 (suppl. 1): 187-202.
155. Timar J, Bartha DC, Ladanyi A, Tarcsafalvi A, Lapis K. PMA induces shift from chondroitin to heparan sulphate on proteoglycans correlating with fibronectin adhesion of MDS human leukemia cells. Anticancer Res 1994; 14: 1227-31.
156. Gordon MY, Clarke D, Atkinson J, Greaves MF. Hemopoietic progenitor cell binding to stroma microenvironment in vitro. Exp Hematol 1990; 18: 837-42.
157. Kanakura Y, Ikeda H, Kitayman H, Sugahara H, Furitsu T. Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells. Leuk Lymphoma 1993; 10: 35-41.
158. + progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. Exp Hematol 1995; 23: 1535-42.
159. Varki A. Selectin ligands. Proc Natl Acad Sci USA 1994; 91: 7390-7.
160. Folkman J, Shiy Y. Angiogenesis. J Biol Chem 1992; 267: 10931-4.
161. Iizuka Y, Aiso M, Oshimi K, Kanemaru M, Kawamura M, Takeuchi J, et al. Myeloblastoma formation in acute myeloid leukemia. Leuk Res 1993; 16: 665-71.
162. Stucki A, Cordey AS, Monai N, Schapira M, Spertini O. Activation of vascular endothelial cells by leukemic blast cells: a mechanism of leukostasis. Blood 1995; 86: 435a.
163. Torok-Storb B. Cellular interactions. Blood 1988; 73: 373-85.
164. Eaves CJ, Cashman JD, Zoumbos NC, Barnett MJ, Eaves AC. Biological strategies for the selective manipulation of normal and leukemic stem cells. Stem Cells 1993; 22 (suppl. 3): 109-21.
165. Bhatia R, Wayner EA, McGlave PB, Verfaillie CM. Interferonalpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function. J Clin Invest 1994; 94: 384-94.
166. Renshaw MW, McWhirter FJ, Wang JY. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol Cell Biol 1995; 15: 1286-93.
167. Kinashi T, Springer TA. Regulation of cell-matrix adhesion by receptor tyrosine kinases. Leuk Lymphoma 1995; 18: 203-8.
168. Takahira H, Gotoh A, Richie A, Broxmeyer HE. Steel factor enhances integrin-mediated tyrosine pbosphorylation of focal adhesion kinase (pp125FAK) and praxillin. Blood 1997; 89: 1574-84.
169. Bendall LJ, Daniel A, Kortlepel K, Gottlieb DJ. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Hematol 1994; 22: 1252-60.
170. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 1993; 104: 991-9.
171. Janiak M, Hashmi HR, Janowska-Wieczorek A. Use of the matrigel-based assay to measure the invasiveness of leukemic cells. Exp Hematol 1994; 22: 559-65.
172. Olive D, Lopez M, Blaise D, Viens P, Stoppa AM, Brandeley M, et al. Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2. J Immunother 1991; 10: 412-7.
173. Bendall LJ, Kortlepel K, Gottlieb DJ. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1. Leukemia 1995; 9: 677-84.
174. Archimbaud E, Campos L, Vila L, Thomas X. Potential role for non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukemia. Immunology Letters 1994; 39: 13-5.
175. Bendall LJ, Kortlepel K, Bradstock KF, Gottlieb DJ. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells. Leukemia 1995; 9: 999-1005.
176. Aoyagi M, Furusawa S, Waga K, Tsunogake S, Shishido H. Suppression of normal hematopoiesis in acute leukemia: effect of leukemic cells on bone marrow stromal cells and hematopoietic progenitor cells. Intern J Med 1994; 88: 288-95.
177. Kubota A, Okamura S, Shimoda K, Niho Y. Augmented production of interleukin-6 by co-culture of human bone marrow adherent cells and human leukemic cells. Biomed Pharmacother 1993; 47: 379-84.
178. Thomas X, Hirschauer C, Troncy J, Assouline D, Joly MO, Fiere D, Archimbaud E. Serum interleukin-6 levels in adult acute myelogenous leukemia: relationship with disease characteristics and outcome. Leuk Res 1997; 24: 291-300.
179. Wetzler M, Estrov Z, Talpaz M, Kim KJ, Alphonso M, Srinivasan R, Kurzrock R. Leukemia inhibitory factor in long-term adherent layer culture: increased levels of bioactive protein in leukemia and modulation by IL4, IL1, beta, and TNF-alpha. Cancer Res 1994; 54: 1837-42.